Defibrillators Market Size & Share, by Product Type {Implantable Cardioverter, Automated External, Implantable Cardioverter, Advanced Life Support, Wearable Cardiac}; End-user (Hospitals, Medical Centers, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4284
Published Date: Feb 13, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Defibrillators Landscape

Asahi Kasei Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Stryker Corporation
Biotronik SE & Co. KG
Boston Scientific Corporation
ZOLL Medical Corporation
LivaNova PLC
Medtronic plc
Cardiac Science Corporation
Nihon Kohden Corporation
Abbott Laboratories

Browse Key Market Insights with Data Illustration:

Defibrillators Market Size & Share | Forecast Report 2035

In the News

In addition to their Cobalt and Crome Defibrillators, Medtronic plc has received CE Marking for their Cardiac Resynchronization Therapy-Defibrillators and their BlueSync -enabled implants.
ugust 27, 2019: Zoll Medical Corporation has announced that it has completed its previously announced acquisition of Cardiac Science Corporation, a leading provider of AEDs, related accessories, and services.

Frequently Asked Questions (FAQ)

Rising incidence of cardiovascular disease worldwide along with rise in medical expenditures are the major factors driving the growth of the defibrillators market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.

Issues associated with the use of an automated external defibrillator along with availability of non-branded defibrillator are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, ZOLL Medical Corporation, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and Abbott.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, end user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Defibrillators Market Size & Share, by Product Type {Implantable Cardioverter, Automated External, Implantable Cardioverter, Advanced Life Support, Wearable Cardiac}; End-user (Hospitals, Medical Centers, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Companies Dominating the Defibrillators Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the defibrillators market?

What would be the CAGR of defibrillators market over the forecast period?

What are the challenges affecting the defibrillators market growth?

Which region will provide more business opportunities for growth of defibrillators market in future?

Who are the major players dominating the defibrillators market?

How are the company profiles selected?

What are the segments in the defibrillators market?

Which segment captures the largest market size in end user segment in the defibrillators market?